Microfabrication for Drug Delivery
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Koch, Brendan | - |
dc.contributor.author | Rubino, Ilaria | - |
dc.contributor.author | Quan, Fu-Shi | - |
dc.contributor.author | Yoo, Bongyoung | - |
dc.contributor.author | Choi, Hyo-Jick | - |
dc.date.accessioned | 2021-06-22T16:23:44Z | - |
dc.date.available | 2021-06-22T16:23:44Z | - |
dc.date.issued | 2016-08 | - |
dc.identifier.issn | 1996-1944 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/13130 | - |
dc.description.abstract | This review is devoted to discussing the application of microfabrication technologies to target challenges encountered in life processes by the development of drug delivery systems. Recently, microfabrication has been largely applied to solve health and pharmaceutical science issues. In particular, fabrication methods along with compatible materials have been successfully designed to produce multifunctional, highly effective drug delivery systems. Microfabrication offers unique tools that can tackle problems in this field, such as ease of mass production with high quality control and low cost, complexity of architecture design and a broad range of materials. Presented is an overview of silicon-and polymer-based fabrication methods that are key in the production of microfabricated drug delivery systems. Moreover, the efforts focused on studying the biocompatibility of materials used in microfabrication are analyzed. Finally, this review discusses representative ways microfabrication has been employed to develop systems delivering drugs through the transdermal and oral route, and to improve drug eluting implants. Additionally, microfabricated vaccine delivery systems are presented due to the great impact they can have in obtaining a cold chain-free vaccine, with long-term stability. Microfabrication will continue to offer new, alternative solutions for the development of smart, advanced drug delivery systems. | - |
dc.format.extent | 36 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MDPI Open Access Publishing | - |
dc.title | Microfabrication for Drug Delivery | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3390/ma9080646 | - |
dc.identifier.scopusid | 2-s2.0-84984614492 | - |
dc.identifier.wosid | 000380762000037 | - |
dc.identifier.bibliographicCitation | Materials, v.9, no.8, pp 1 - 36 | - |
dc.citation.title | Materials | - |
dc.citation.volume | 9 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 36 | - |
dc.type.docType | Review | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Multidisciplinary | - |
dc.subject.keywordPlus | MICRONEEDLE-TREATED SKIN | - |
dc.subject.keywordPlus | TRANSDERMAL DELIVERY | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | CONTROLLED-RELEASE | - |
dc.subject.keywordPlus | VACCINE DELIVERY | - |
dc.subject.keywordPlus | ORAL DELIVERY | - |
dc.subject.keywordPlus | DISSOLVING MICRONEEDLES | - |
dc.subject.keywordPlus | 2-PHOTON POLYMERIZATION | - |
dc.subject.keywordPlus | CAPSULE ENDOSCOPY | - |
dc.subject.keywordPlus | TARGETED DELIVERY | - |
dc.subject.keywordAuthor | microfabrication | - |
dc.subject.keywordAuthor | drug delivery | - |
dc.subject.keywordAuthor | biocompatibility | - |
dc.identifier.url | https://www.mdpi.com/1996-1944/9/8/646 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.